METSERA
HQ - New York
Summary
Metsera is a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 233 M
Avg. Deal Size£ 233 M
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite
